David Y. Takeda
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 1
- Molecular Biology top 10%
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 3
- CRISPR and Genetic Engineering 2
-
- Prostate Cancer Treatment and Research 7
- Cell Biology top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 2
-
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Anindya DuttaJames A. WohlschlegelJeffrey D. ParvinWilliam C. HahnHenry W. LongMark M. PomerantzMatthew L. FreedmanPaloma Cejas
- Partner nations
- United StatesDenmarkSingapore
In The Last Decade
David Y. Takeda
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Cancer Research 239
- Molecular Biology 895
- Pulmonary and Respiratory Medicine 404
- Cell Biology 184
- Oncology 255
Countries citing papers authored by David Y. Takeda
This map shows the geographic impact of David Y. Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y. Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y. Takeda more than expected).
Fields of papers citing papers by David Y. Takeda
This network shows the impact of papers produced by David Y. Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y. Takeda. The network helps show where David Y. Takeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Y. Takeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2018 | 202 | |
| 6 | 2018 | 71 | |
| 7 | 2018 | 31 | |
| 8 | 2016 | 8 | |
| 9 | 2015 | 266 | |
| 10 | 2014 | 14 | |
| 11 | 2005 | 154 | |
| 12 | 2005 | 58 | |
| 13 | 2005 | 85 | |
| 14 | 2004 | 70 | |
| 15 | 2001 | 106 | |
| 16 | 2001 | 68 | |
| 17 | 1998 | 46 | |
| 18 | EXPRESSION OF THE EPA SYNTHESIS GENE CLUSTER FROM SHEWANELLA SP. IN A TRANSGENIC MARINE CYANOBACTERIUM, SYNECHOCOCCUS SP | 1997 | 1 |
| 19 | 1994 | 5 |
About David Y. Takeda
David Y. Takeda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), DNA Repair Mechanisms (4 papers), Epigenetics and DNA Methylation (4 papers), Genomics and Chromatin Dynamics (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer-related Molecular Pathways (2 papers) and Carcinogens and Genotoxicity Assessment (1 paper). The work is most often cited by research in Cancer Research (239 citations), Molecular Biology (895 citations) and Pulmonary and Respiratory Medicine (404 citations). David Y. Takeda has collaborated with scholars based in United States, Denmark and Singapore. Frequent co-authors include Anindya Dutta, James A. Wohlschlegel, Jeffrey D. Parvin, William C. Hahn, Henry W. Long, Mark M. Pomerantz, Matthew L. Freedman, Paloma Cejas, Yoshiyuki Shibata and Rosina T. Lis. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.